Interdisciplinary Management of Cardiotoxicity in Outpatient Settings: A Survey on Practices, Perceptions and Potential for Improvement
Our study underscores potential interdisciplinary care gaps, possibly increasing the risk of undetected cardiotoxicity. Variations in cardiotoxicity management among specialities highlight the need for increased awareness and improved collaboration. Interdisciplinary clinical pathways could address these issues, as could a dedicated cardio-oncology network for primary care physicians' support.
Authors
- Silvio Quick (ORCID: https://orcid.org/0000-0002-8599-4790)
- Tina Haase (ORCID: https://orcid.org/0000-0002-9325-4098)
- Lorenz Harst (ORCID: https://orcid.org/0000-0002-6004-2670)
- Markus Koesters (ORCID: https://orcid.org/0000-0001-7018-6021)
- Jochen Schmitt (ORCID: https://orcid.org/0000-0003-0264-0960)
- Marian Christoph (ORCID: https://orcid.org/0000-0003-4053-4202)
- Lorena Payo-Anez (ORCID: https://orcid.org/0009-0008-2604-7962)
- Karim Ibrahim (ORCID: https://orcid.org/0000-0002-3511-5532)
- Carlota Tuñón de Almeida
Institutions
- University Hospital Carl Gustav Carus (DE)
- Klinikum Chemnitz (DE)
Publication Details
- Journal
- European Cardiology Review
- Published
- 2025-02-13
- DOI
- https://doi.org/10.15420/ecr.2023.49
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- Pfizer
- Sanofi
- Volkswagen Foundation
- Bundesministerium für Bildung und Forschung
- Bundesministerium für Gesundheit